Close Menu
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
What's Hot

Why did Iran choose to resume fighting after the US ceased bombardment?

July 30, 2026

Cyera agrees to acquire Oasis Security for $1 billion to protect burgeoning AI agents

July 30, 2026

Starbucks (SBUX) Q3 2026 Earnings

July 30, 2026
Facebook X (Twitter) Instagram
Smart Breaking News on AI, Business, Politics & Global Trends | WhistleBuzz
Facebook X (Twitter) Instagram
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
Smart Breaking News on AI, Business, Politics & Global Trends | WhistleBuzz
Home » We aim to further reduce this drug stock and exit from this entertainment giant
US

We aim to further reduce this drug stock and exit from this entertainment giant

Editor-In-ChiefBy Editor-In-ChiefNovember 14, 2025No Comments3 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email Copy Link
Follow Us
Google News Flipboard
Share
Facebook Twitter LinkedIn Pinterest Email


Jim Cramer’s CNBC Investment Club hosts a “Morning Meeting” livestream every weekday at 10:20 a.m. ET. A recap of Friday’s key moments. 1. The S&P 500 rose on Friday. The index opened lower after posting its worst one-day performance since October 10. Still, Wall Street remains wary of Big Tech companies’ heavy spending and inflated valuations. Jim Cramer cautioned investors to stick with profitable companies (like club names Nvidia, Microsoft and Alphabet) rather than companies that make irreversible promises. Our trusted S&P short range oscillator is not oversold yet, but we are keeping an eye on select buying opportunities among stocks that have fallen. We’re gearing up to free up more cash as the terrestrial television network looks to exit Disney, which is squeezing profits. Jim said Disney is “in denial” about their challenge. 2. Shares of drugmaker Bristol-Myers fell more than 3.5% on Friday after a Phase 3 trial of one of the company’s experimental drugs was halted due to patient health issues. The drug in question was not the schizophrenia drug Cobenfi, which we were bullish about for its potential use in Alzheimer’s disease. A major announcement regarding Cobenfy is expected by the end of the year. This is a make-or-break update for us as investors, given management’s consistent issues with execution. “It’s hard to trust management after a series of mistakes,” said portfolio director Jeff Marks. We have sold stock and, as Jim said at Thursday’s November meeting, we will consider selling more if the stock resumes its recent rally. 3. Looking ahead to next week, four club names will report earnings, starting with Home Depot before the opening bell on Tuesday. The current rise in mortgage rates makes it difficult to maintain a positive stance in a short-term setting. At the same time, there is a large amount of pent-up demand in the housing sector, which should benefit home improvement retailers. Next up is TJX before the opening bell on Wednesday. Off-price retailers tend to exceed the highest guidance prices, so it’s a story of significantly under-promising and over-delivering. Nvidia also reported Wednesday, but after the final bell. Although there are many bears on the stock right now, Jim maintains his stance of “holding my stock and not trading it.” Finally, cybersecurity company Palo Alto Networks will report after the bell on Wednesday, but we’re interested to hear how management plans to strengthen agent-based security. 4. The stocks featured at the end of Friday’s video were Applied Materials, Walmart, Gap, and Nucor. (Jim Cramer’s charitable trusts are long DIS, BMY, HD, TJX, NVDA, PANW. See here for a complete list of stocks.) As a subscriber to Jim Cramer’s CNBC Investment Club, you will receive trade alerts before Jim makes a trade. After Jim sends a trade alert, he waits 45 minutes before buying or selling stocks in his charitable trust’s portfolio. If Jim talks about a stock on CNBC TV, he will issue a trade alert and then wait 72 hours before executing the trade. The above investment club information is subject to our Terms of Use and Privacy Policy, along with our disclaimer. No fiduciary duties or obligations exist or arise from your receipt of information provided in connection with the Investment Club. No specific results or benefits are guaranteed.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Editor-In-Chief
  • Website

Related Posts

SpaceX Memphis AI data center faces demands from House Energy Committee

July 30, 2026

Inside India Newsletter: Gen Z protests raise Instagram profile in India

July 29, 2026

Microsoft’s AI spending guide is music to our ears and calming the bears for now

July 29, 2026
Add A Comment

Comments are closed.

News

President Trump says US will deal ‘strikes’ to Iran after base targeted again | US and Israel’s war against Iran News

By Editor-In-ChiefJuly 30, 2026

US President Donald Trump has promised a major escalation against Iran following recent Iranian attacks…

Fauci invokes Fifth Amendment to U.S. Constitution during heated Senate hearing on coronavirus infection | Political News

July 29, 2026

Democratic senators ask U.S. Securities and Exchange Commission to investigate Trump Media high-speed feed sales | Donald Trump News

July 29, 2026
Top Trending

Cyera agrees to acquire Oasis Security for $1 billion to protect burgeoning AI agents

By Editor-In-ChiefJuly 30, 2026

Data security company Cyera, which recently raised $600 million at a $12…

Pangram raises $9M to detect AI content as it floods the internet

By Editor-In-ChiefJuly 29, 2026

Pangram, a New York-based AI detection startup on a mission to combat…

Encore AI raises $30M to build AI agent that learns from customer calls

By Editor-In-ChiefJuly 29, 2026

Encore AI, a startup that studies companies’ customer interactions and trains and…

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Welcome to WhistleBuzz.com (“we,” “our,” or “us”). Your privacy is important to us. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you visit our website https://whistlebuzz.com/ (the “Site”). Please read this policy carefully to understand our views and practices regarding your personal data and how we will treat it.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Facebook X (Twitter) Instagram Pinterest
  • Home
  • Advertise With Us
  • Contact US
  • DMCA Policy
  • Privacy Policy
  • Terms & Conditions
  • About US
© 2026 whistlebuzz. Designed by whistlebuzz.

Type above and press Enter to search. Press Esc to cancel.